Search

everythinglearnresearchcommunity

for

Search:↓

The boy's skin condition improved significantly with a specific ointment after other treatments showed only mild results.

Higher RBP4 levels found in people with two types of hair loss.

Technique effectively reconstructs large scalp defects with minimal hair loss and visible scarring.

RCM and dermoscopy help identify different types of hair loss in children.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

A rare genetic mutation causes resistance to vitamin D, leading to severe rickets and requires high doses of calcium and vitamin D for management.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Proper antifungal treatment is crucial to avoid misdiagnosis and prevent scarring alopecia.

Surgery can effectively treat severe eyelid turning out caused by a rare skin disorder.

Scalp biopsies are essential for diagnosing congenital alopecia areata.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Promising cancer treatments were found, but the manufacturer closed.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

Retinoic acid affects hair growth and can cause hair loss.

Mexican hairless dogs can help test new skin treatments.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

Calretinin identifies the companion cell layer in human hair follicles.

Ritlecitinib works well and is safe for treating alopecia areata.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

An extremely low-birthweight infant had a rare genetic skin disease and died despite treatment.

A patient with steroid sulfatase deficiency had a unique hair pattern and a brain malformation not previously linked to the condition.

Keratosis Pilaris Atrophicans causes skin scarring and might be treated with a new synthetic retinoid.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.